{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:14:07Z","timestamp":1791695647189,"version":"4.3.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1378\/chest.123.1.102","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"102-106","source":"Crossref","is-referenced-by-count":108,"title":["Pyrazinamide and Rifampin vs Isoniazid for the Treatment of Latent Tuberculosis"],"prefix":"10.1016","volume":"123","author":[{"given":"Lee","family":"McNeill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.123.1.102_bib1","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.1.102_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid vs rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.123.1.102_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin, and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.123.1.102_bib4","first-page":"911","article-title":"Use of short-course tuberculosis preventative therapy regimens in HIV-seronegative persons","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.123.1.102_bib5","first-page":"289","article-title":"Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: New York and Georgia, 2000","volume":"50","author":"Centers for Disease Control","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.123.1.102_bib6","first-page":"733","article-title":"Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revision in American Thoracic Society\/CDC recommendations: United States, 2001","volume":"50","author":"Centers for Disease Control update","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Pt 2","key":"10.1378\/chest.123.1.102_bib7","first-page":"A437","article-title":"Short-course preventive therapy for tuberculosis [abstract]","volume":"141","author":"Geiter","year":"1990","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.1.102_bib8","unstructured":"Geiter, LJ. Results of a randomized, controlled trial to assess the toxicity and patient adherence with two short-course regimens for the prevention of tuberculosis, a two-month regimen of rifampin and pyrazinamide or a four-month regimen of rifampin only, in comparison with a control regimen of six months-isoniazide [thesis]. Baltimore, MD: Johns Hopkins University, School of Hygiene and Public Health"},{"key":"10.1378\/chest.123.1.102_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1378\/chest.119.3.833","article-title":"Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates","volume":"119","author":"Bock","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.123.1.102_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-76-3-112-6-397","article-title":"USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability","volume":"112","author":"Combs","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.1.102_bib11","first-page":"761","article-title":"Compliance and tolerance of new antituberculotic short-term chemoprevention regimes in childhood: a pilot study","volume":"48","author":"Magdorf","year":"1994","journal-title":"Pneumologie"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216343811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216343811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:23:35Z","timestamp":1553099015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216343811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0012369216343811"],"URL":"https:\/\/doi.org\/10.1378\/chest.123.1.102","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}